Peter Held - Concepedia

Author

Peter Held

Brigham and Women's Hospital

Also Known As

Bradley A. Bart, Mats O. Karlsson, P HELD, P Held, P. HELD, P. Held, Peter Held

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital AstraZeneca (Sweden)Thrombolysis in Myocardial Infarction Study Group Université Paris Cité University of Sheffield

About

Peter Held is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.3K
2	Engineering	1	1	17
3	Health Sciences	1	1	17
4	Biochemistry	1	1	11
5	Diabetes	1	1	216

Peter Held

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen, New England Journal of Medicine	2015	1.9K
CHARM INVESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT-VENTRICULAR EJECTION FRACTION: THE CHARM-PRESERVED TRIAL Salim Yusuf, Pfeffer, Karl Swedberg, Heart FailureCardiovascular DiseaseCardiovascular PharmacologyCharm-preserved TrialCardiac Care	2003	436
Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction James B. Young, Mark E. Dunlap, Marc A. Pfeffer, Circulation	2004	393
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease Marc P. Bonaca, Deepak L. Bhatt, Robert F. Storey, Journal of the American College of Cardiology ThrombosisHeart FailureCardiovascular DiseaseAtherosclerosisMedicine	2016	383
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54 Deepak L. Bhatt, Marc P. Bonaca, Sameer Bansilal, Journal of the American College of Cardiology ThrombosisCardiovascular DiseasePrior Myocardial InfarctionDiabetesPharmacology	2016	216
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y <sub>12</sub> inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 Marc P. Bonaca, Deepak L. Bhatt, Philippe Gabríel Steg, European Heart Journal	2015	164
Short- and long-term neurohormonal activation following acute myocardial infarction Axel F. Sigurðsson, Peter Held, Karl Swedberg American Heart Journal Cardiovascular DiseaseNeurophysiologyMedicineNeuroprotectionNeurology	1993	133
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events Marc P. Bonaca, Deepak L. Bhatt, Ton Oude Ophuis, JAMA Cardiology	2016	97
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial Giulia Magnani, Robert F. Storey, Philippe Gabríel Steg, European Heart Journal	2015	82
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease Sameer Bansilal, Marc P. Bonaca, Jan H. Cornel, Journal of the American College of Cardiology ThrombosisMultivessel Coronary DiseaseCardiovascular DiseaseSecondary PreventionVascular Surgery	2018	70

Page 1